Breaking News:
Dr. Koda-Kimble, Rep. Waxman Honored at APhA meeting
Clinical pharmacy pioneer Mary Anne Koda-Kimble, PharmD, and Congressman Henry Waxman (D-Calif.) were among those honored last weekend at the Annual Meeting and Exposition of the American Pharmacists Association (APhA) in Washington, D.C. More...
Voluntary reporting of medication errors through ISMP has an impact
The Institute for Safe Medication Practices (ISMP), a nonprofit organization devoted to medication error prevention and safe medication use, has a voluntary practitioner error-reporting program that has helped to identify a variety of medication errors and their causes. More...
FDA approvals:
First direct thrombin inhibitor cleared for DVT prevention
The FDA-approved desirudin for injection (Iprivask, Canyon Pharmaceuticals), now available, marks the first direct thrombin inhibitor (DTI) available for the prevention of deep vein thrombosis (DVT). More...
Injection pen will aid those with growth hormone-related conditions
Somatropin [rDNA origin] injection (Norditropin FlexPro, Novo Nordisk), a pre-filled injection pen for use in children and adults with growth hormone disorders, will be available this spring, based on recent FDA approval. More...
Investigational Drugs:
Transdermal patch in development stages may prove beneficial in migraine treatment
Data from a phase-3 trial investigating a transdermal patch (Zelrix, NuPathe) for the management of acute migraine showed the patch met the primary efficacy end point of improvement in pain freedom for 2 hours post-patch application. More...
Investigational drug may boost survival for certain prostate cancer patients
Cabazitaxel, an investigational compound under development by Sanofi-Aventis, plus prednisone/prednisolone, is associated with improved overall survival and progression-free survival in patients with metastatic (advanced) hormone-refractory prostate cancer whose disease advanced after treatment with docetaxel-based chemotherapy. More...
Drug Launch:
Opioid analgesic on market for cancer pain management
An FDA-approved, oral transmucosal fentanyl citrate and opioid analgesic (Mallinckrodt Inc., a Covidien company) for cancer pain management, is being launched. FDA cleared the Abbreviated New Drug Application (ANDA) for the generic substance in October 2009. More...
Professional News:
Survey shows pharmacists' loyalty to patients regardless of weather
Despite a challenging 2009-10 winter, the majority of pharmacists across 26 states (79% of respondents) that were affected by the snow largely managed to keep standard business hours, according to a survey conducted by the National Community Pharmacists Association. More....
Rep. Marion Berry garners NACDS leadership award
The National Association of Chain Drug Stores (NACDS) awarded Rep. Marion Berry the NACDS Congressional Leadership Award for his ongoing support of pharmacy. More...
Meetings:
April 7-10, 2010 Academy of Managed Care Pharmacy
San Diego, CA
Contact:
100 North Pitt Street, Suite 400
Alexandria VA 22314
Phone: 703-683-8416
Fax: 703-683-8417
April 24-27 NACDS
Palm Beach, FL
Contact:
P.O. Box 34814
Alexandria, Virginia 22334-0814
703-837-4300
May 2-6 National Council for Prescription Drug Programs
Scottsdale, AZ
9240 East Raintree Drive
Scottsdale, AZ 85260-7518
Phone: 480-477-1000 ext. 110
Fax: 480-222-7555
May 26-28 ASCP Midyear
Phoenix, AZ
Contact:
1321 Duke Street
Alexandria, VA 22314-3563
Phone: 703-739-1300
May 10-12 NCPA National Legislation & Government Affairs Conference
Washington, D.C.
Contact:
100 Daingerfield Road
Alexandria, VA 22314
Phone: 703-683-8200 voice 800-544-7447
Fax: 703-683-3619
May 22-25 NABP
Anaheim, CA
Contact:
1600 Feehanville Drive
Mount Prospect, IL 60056
Phone: 847-391-4406
Fax: 847-391-4502
|
